Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

ESTRADIOL VALERATE AND DIENOGEST

DIENOGEST; ESTRADIOL VALERATE

Standard Dose
N/A,2MG,3MG,N/A,N/A;3MG,2MG,2MG,1MG,N/A
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview ESTRADIOL VALERATE AND DIENOGEST is listed in Drugs@FDA under application 202349 (ANDA).

Marketing status: Prescription Active ingredient DIENOGEST; ESTRADIOL VALERATE Form and strength TABLET;ORAL - N/A,2MG,3MG,N/A,N/A;3MG,2MG,2MG,1MG,N/A Sponsor WATSON LABS INC Submission history Latest submission status date: 2017-05-09 00:00:00.

Structured Monograph

Clinical summary

Approval overview ESTRADIOL VALERATE AND DIENOGEST is listed in Drugs@FDA under application 202349 (ANDA). Marketing status: Prescription Active ingredient DIENOGEST; ESTRADIOL VALERATE Form and strength TABLET;ORAL - N/A,2MG,3MG,N/A,N/A;3MG,2MG,2MG,1MG,N/A Sponsor WATSON LABS INC Submission history Latest submission status date: 2017-05-09 00:00:00. Submission type: ORIG.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.